Navigation Links
Merck/Gilead Once-A-Day AIDS Pill Not Available in Most Places - AHF Urges Speed-Up of Registrations
Date:9/10/2007

The once-daily HIV treatment would greatly increase effectiveness for patients, but Gilead Sciences and Merck and Co. have failed to register it

in countries where it is needed most

LOS ANGELES, Sept. 10 /PRNewswire-USNewswire/ -- AIDS Healthcare Foundation (AHF) today called on Gilead Sciences and Merck to immediately register and distribute the three-in-one, once daily lifesaving HIV treatment, Atripla, in developing countries. When Atripla first received approval from the Food and Drug Administration (FDA) in July of 2006, advocates like AHF applauded the production of a single, once-a-day drug as a landmark step in treating HIV. However, since its approval, little progress has been made in expanding the availability of the treatment in the developing world, where only 28% of those in need of treatment were able to access it as of December 2006. Efforts made by AHF to clarify what countries currently can purchase Atripla at the announced $613 per patient per year access price have gone unanswered.

"This treatment is a standard therapy in the United States. It is on the World Health Organization's Essential Medicines List, and is an antiretroviral drug regimen that could greatly benefit patients everywhere while reducing costs in the long term," said Michael Weinstein, AIDS Healthcare Foundation President. "The fact that Gilead and Merck appear to be unable or unwilling to make it available in resource-poor countries is deeply troubling, and causing unnecessary suffering. Gilead and Merck should immediately begin making this treatment available to the rest of the world, or license it out to a generic drug manufacturer, such as Cipla, which already produces a generic version in India, that will. In the instances where the registration process has been initiated such as in the European Union, governments must also recognize their roles and streamline the necessary approval processes to facilitate quick distribution of these
'/>"/>

SOURCE AIDS Healthcare Foundation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Positive Results Prompt US National Cancer Institute to Make Glivec Available to Patients in Post-Surgical GIST Study
3. Positive Results Prompt US National Cancer Institute to Make Gleevec Available To Patients in Post-Surgical Gist Study
4. Data Available from Erbitux Phase III Study in First-Line Treatment of Advanced Pancreatic Cancer
5. Survival Data Available From Erbitux Study in First-Line Treatment of Advanced Head and Neck Cancer
6. Survival Data Available from Erbitux Study in First-Line Treatment of Advanced Head and Neck Cancer
7. The American Liver Foundation Urges Cautious Optimism about CDC Report on Declining Acute Hepatitis Infection Rates

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... American Scientific Reso...pleased to announce that they have opened a region...hanghai, China. ,, ASR has been able to secure ...for the development and production of current and ... adults to be distributed and sold globally. Curr...
(Date:11/25/2009)...nd, Nov. 25 From November 16-18, ...ring solutions, presented the second edition of th...the special needs of the older population. The con...and audiology from around the world and more than ... with hearing loss for an opportunity to share exp...
(Date:11/25/2009)... 25 AMPAC Fine Chemicals LLC (AFC)...sdaq: APFC ) announced today that it received the...ward at the Annual Statewide Environmental Summit,...hnology Association (CMTA), the Industrial Environ... Council of California (CICC) held in San Diego. ...
Breaking Medicine Technology:American Scientific Resources Inc. Opens Shanghai Location 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 3OTCBB VHGI Announces LOI to Sell Certain Assets for 2410 Million Cash Stock to WNDM 3B With Stock Dividend to be Distributed to Shareholders in 2010 6017 1OTCBB VHGI Announces LOI to Sell Certain Assets for 2410 Million Cash Stock to WNDM 3B With Stock Dividend to be Distributed to Shareholders in 2010 6017 2OTCBB VHGI Announces LOI to Sell Certain Assets for 2410 Million Cash Stock to WNDM 3B With Stock Dividend to be Distributed to Shareholders in 2010 6017 3Custom Spine Receives 510k Clearance of Regent ACP 6014 1Custom Spine Receives 510k Clearance of Regent ACP 6014 2Bayer Consumer Care Launches Citracal 28R 29 Calcium Plus Heart Health First Ever Leading Calcium Supplement to Help Support Bone AND Heart Health 6011 1Bayer Consumer Care Launches Citracal 28R 29 Calcium Plus Heart Health First Ever Leading Calcium Supplement to Help Support Bone AND Heart Health 6011 2Bayer Consumer Care Launches Citracal 28R 29 Calcium Plus Heart Health First Ever Leading Calcium Supplement to Help Support Bone AND Heart Health 6011 3
...(BUSINESS WIRE)--Jun 25, 2007 - Neurogen,Corporati...e,results from two dose-ranging, Phase 2b clinical...any,s proprietary insomnia agent,NG2-73, an alpha...rmulations were studied in each trial to determine...maintenance of sleep,through the night without res...
...f.--(BUSINESS WIRE)--Jun 25, 2007 - Gilead,Science...03, a,Phase III clinical trial evaluating the comp...r disoproxil fumarate or tenofovir,DF) 300 mg as a...,(HBV) infection, met its primary efficacy endpoin...e company,s once-daily antiviral,drug Hepsera(R) (...
Other Medicine Technology:Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 2Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 3Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 4Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 5Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 6Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 7Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 8Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 2Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 3Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 4Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 5Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 6
(Date:11/27/2009)... Specialist manufacturers who...ucts are saving millions of dollars by bringing in...ocess. Increasing numbers of pro-active medical ma...ts at the concept stage of their projects, ensurin...g design processes or potentially outdated technol...
(Date:11/26/2009)... , PRINCETON, N.J., Nov. 27 ... almost double over the next 25 years and annual m... $336 billion, up from $113 billion today, accordi...Diabetes Care . The National Changing Diabetes &...ommissioned the analysis by a team from the Univer...
(Date:11/26/2009)...age that,s too big or too heavy can lead to strain...Day News) -- There may be nothing wrong with stuff...t want to do the same thing with your suitcase as ...people were treated in 2008 in U.S. hospital emerg...dical facilities for luggage-related injuries, suc...
(Date:11/26/2009)... Dr. David Kim of the Live Li...surgery in Dallas , is one of a growing number of ...cial networking sites to connect with individuals ...nt to fight morbid obesity. Dr. Kim is utilizing F...mation about his practice with the community. , ...
(Date:11/26/2009)... Ennis & Ennis, P.A. is o... for users of Yaz and Yasmin birth control pills w...monary Embolism, Stroke, Heart Attack or other rel...ed. Women can call toll free at 1-800-856-6405 or ...slaw.com and fill out an online case evaluation f...
Breaking Medicine News(10 mins):Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3
...g in the October issue of the journal Pediatrics s...lk is more than that of Cow's milk. Dr. Ruth...New York and her colleague Dr. William H. Bowen us... when they were fed sweet liquids like soda and ho...
...ed in the treatment of Multiple Sclerosis (MS), ha...s taking the drug complained of neurological disor...gressive Multifocal Leukoencephalopathy (PML) is b...h work by blocking passage of immune cells in to t...
...rize meant swallowing a glassful of dangerous bact...ssor Barry Marshall however did just that. He swal...ach ulcers are bacterial in origin rather than str...ates for Medicine in the current year. "I didn't t...
...10 countries estimated to have the highest number ...US following closely. Type II Diabetes, one of the...ining // epidemic proportions throughout the world...idity and mortality due to long-term micro and mac...
...as advanced so much to the extent of replacing los...ing artificial implants. These implantable devices...od // alternative to the conventional treatment. ...ality of these tiny, yet useful devices. Designed ...
... been reported at a seniors' home in Toronto and e... have caused the death of four residents at the ho... that there was // no cause to fear an outbreak an... a significant burden of disease," he said. All th...
Other Medicine News:Health News:Nobel For Ulcer-Defying Aussie Scientists 2Health News:A new anti diabetic drug on the anvil 2Health News:Implantable devices to be powered by organosilicon compounds in the future 2
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
Medicine Products: